AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $786,017 | -8.3% | 62,581 | -19.1% | 0.36% | -48.4% |
| Q1 2023 | $857,412 | -9.2% | 77,314 | 0.0% | 0.70% | +24.6% |
| Q4 2022 | $944,004 | +31.3% | 77,314 | +12.3% | 0.56% | +36.3% |
| Q3 2022 | $719,000 | -25.8% | 68,830 | -23.7% | 0.41% | -29.7% |
| Q2 2022 | $969,000 | -5.5% | 90,234 | -16.6% | 0.58% | -10.3% |
| Q1 2022 | $1,025,000 | -21.8% | 108,257 | -4.5% | 0.65% | -37.5% |
| Q4 2021 | $1,310,000 | +21.0% | 113,387 | 0.0% | 1.04% | +45.5% |
| Q3 2021 | $1,083,000 | +33.2% | 113,387 | +34.4% | 0.72% | +24.3% |
| Q2 2021 | $813,000 | -11.4% | 84,371 | +112.1% | 0.58% | -1.5% |
| Q4 2020 | $918,000 | +97.8% | 39,774 | +20.9% | 0.59% | +73.4% |
| Q3 2020 | $464,000 | +14.6% | 32,893 | +22.4% | 0.34% | +0.9% |
| Q2 2020 | $405,000 | – | 26,863 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Morgenthaler Management Partners IX, LLC | 1,783,948 | $17,304,000 | 18.83% |
| FRAZIER MANAGEMENT LLC | 2,918,291 | $28,307,000 | 11.84% |
| Avoro Capital Advisors LLC | 3,515,611 | $34,101,000 | 11.75% |
| Perceptive Advisors | 15,239,444 | $147,823,000 | 10.94% |
| Redmile Group, LLC | 10,280,620 | $99,722,000 | 7.46% |
| ACUTA CAPITAL PARTNERS, LLC | 1,502,661 | $14,576,000 | 6.97% |
| SECTORAL ASSET MANAGEMENT INC | 7,973,436 | $77,342,000 | 3.30% |
| Asymmetry Capital Management, L.P. | 195,206 | $1,893,000 | 2.86% |
| Convector Capital Management, LP | 210,500 | $2,042,000 | 1.92% |
| Palo Alto Investors LP | 3,551,173 | $34,446,000 | 1.92% |